A Phase 2 interventional study of Skin Cell Dip and Stem Cell Dip in Mobility Impairment, Clinical Workflow Optimization and Sanitation Protocol Compliance, sponsored by Truway Health, Inc.. Enrolling by invitation at 4 sites in 3 countries. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Truway Health, Inc. · Phase 2, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.
The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations.
Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard.
Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion.
This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.
Truway Health, Inc. is the lead sponsor of 16 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Age 18-75 years
Able to provide
Facility staff, clinical auditors, ESG observers, or coalition stakeholders
Willing to interact with humanoid robotics in clinical workflows
Available for biometric feedback and observational logging over 90 days
Exclusion Criteria:
- Cognitive impairment preventing
Active infectious disease requiring isolation
Prior adverse reaction to biotech-enhanced robotics
Involvement in conflicting clinical trials
Inability to comply with protocol procedures or coalition transparency requirements
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Humanoid units deployed in patient intake and sanitation roles. Enhanced with keratinocyte-based skin cell dips to improve tactile sensitivity and surface regeneration. Assigned Roles: Intake assistant, sanitation technician Biometric Focus: Motor function, ESG compliance
Biological: Skin Cell Dip
Humanoid units deployed in mobility and R\&D support roles. Enhanced with iPSC-derived stem cell dips targeting neural responsiveness and adaptive learning. Assigned Roles: Mobility assistant, lab technician Biometric Focus: Cognitive response, biotech retention
Biological: Stem Cell Dip
Humanoid units deployed in ESG-linked sanitation and logistics roles. Monitored for energy usage, carbon offset, and protocol adherence. Assigned Roles: ESG sanitation, logistics handler Biometric Focus: ESG compliance, human interaction
Behavioral: ESG Compliance Monitoring, Operational protocol
Humanoid units deployed in public interface and intake roles. Wage tokens minted based on biometric audit scores and task completion. Assigned Roles: Receptionist, intake coordinator Biometric Focus: Wage token distribution, interaction scoring
Other: Wage Token Distribution
Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.
iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.
HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.
Also known as: Blockchain-based compensation
Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.
Biometric Audit Score ≥85 Across Five Performance Dimensions
This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.
Time frame: Measured at Day 30 Post-Deployment
ESG Audit Compliance Score ≥90
Measured at Day 60 Post-Deployment
Time frame: Humanoid units are evaluated for ESG-linked performance including energy usage, sanitation protocol adherence, and carbon offset metrics. Scores are published to the coalition dashboard and notarized via SHA-256. Units scoring ≥90 contribute to DAO-backe
Wage Token Distribution Volume per Unit
Tracks the volume of HumanoidWage (HMW) tokens minted and distributed to each humanoid unit based on biometric audit scores and task completion. Token flow is logged on-chain and used to calibrate coalition wage pools and reinvestment logic.
Time frame: Continuous Monitoring Over 90 Days
Clinical Workflow Efficiency Increase ≥15%
Assesses improvements in patient intake speed, sanitation cycle time, and mobility assistance throughput across facilities. Benchmarked against pre-deployment baselines and validated by coalition auditors.
Time frame: Measured at Day 90 Post-Deployment
Plan to share: Yes — Individual participant data (IPD) collected during this trial-including biometric audit scores, ESG compliance metrics, and wage token distribution logs-will be shared with qualified researchers upon request. Data will be de-identified, SHA-256 notarized, and made available through Truway Health's coalition dashboard and secure data access portal. Access will require submission of a research proposal, DAO approval, and compliance with coalition transparency protocols.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: IPD and supporting documents will be available starting April 1, 2026, following primary study completion. Access will remain open for 5 years, until April 1, 2031, via Truway Health's secure coalition dashboard and data access portal.
Access criteria: Qualified researchers, coalition partners, and regulatory agencies may request access to de-identified IPD, biometric scores, ESG metrics, wage token logs, and analytic code. Access requires submission of a research proposal, DAO approval, and compliance with Truway Health's transparency and data governance protocols.
Data sharing details ↗ · www.truwayhealth.com
Started Oct 2025 (actual). Primary completion is estimated for Oct 2031, 72 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.